The risk of thrombosis in women increases significantly during treatment with hormonal therapy (HT). The aim of this study was to evaluate ProC Global assay in women with a history of venous thromboembolism (VTE) while using HT...
Keywords: Thrombophilic risk factor, Oral contraceptive, Hormonal therapy, ProC Global assay
11/2006 | Thrombosis and Haemostasis, Schattauer